Bright Minds Biosciences Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for DRUG stock have an average target of 80, with a low estimate of 75 and a high estimate of 85. The average target predicts an increase of 117.51% from the current stock price of 36.78.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$75	$80	$85	$85
Change	+103.92%	+117.51%	+131.10%	+131.10%

Analyst Ratings

The average analyst rating for DRUG stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25
Strong Buy	0	1
Buy	1	2
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Charles Duncan Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Jan 10, 2025
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $85	Strong Buy	Initiates	$85	+131.10%	Jan 10, 2025
Joel Beatty Baird	Baird	Buy Initiates $75	Buy	Initiates	$75	+103.92%	Nov 25, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.